Ujvira Trastuzumab 100 Mg Injection
19800 आईएनआर/टुकड़ा
उत्पाद विवरण:
X
मूल्य और मात्रा
- 1
उत्पाद वर्णन
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy. This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.Tell us about your requirement
Price: Â
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
मोबाइल number
Email
कैंसर रोधी औषधियाँ अन्य उत्पाद
DEV MEDICAL
सर्वाधिकार सुरक्षित.(उपयोग की शर्तें)
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
